medRxivGenetic & Genomic MedicinePreprint
Novel Epistatic Interaction Between RBMS3 and CDKN2B-AS1 in Coronary Artery Disease Risk Identified by Machine Learning Tool VariantSpark
Letitia M.F. SngiD, Mitchell J. O’BrieniD, Brendan HoskingiD, Piotr SzuliD, Roc ReguantiD, Mythreye VenkatesaniD, Philip J. FredaiD, Zhiping Paul WangiD, Jason H. MooreiD, Anne H. KleiniD, Michael J. KuiperiD, Angus Panagopoulos, Johan W. H. VerjansiD, Yatish JainiD, Denis C. BaueriD, Natalie A. TwineiD
Abstract
BackgroundGenome-wide association studies (GWAS) of coronary artery disease (CAD), the leading cause of mortality and morbidity globally, have identified approximately 163 risk loci, yet only 40% of CAD genetic heritability can be explained. Non-additive genetic effects, like epistasis, likely contribute to CAD aetiology, but remain elusive due to limited data and insensitive algorithms. ResultsUsing machine-learning (VariantSpark) followed by exhaustive epistasis search (BitEpi), we discovered an epistatic interaction for CAD between RBMS3 and CDKN2B-AS1 in the UK Biobank. We also observe this interaction in the independent All of Us cohort and provide a binding model using AlphaFold3. VariantSpark provides the needed sensitivity, identifying associated loci (e.g. PMAIP1-MC4R and AAK1) with 72% fewer samples than previous studies, to reduce the search space for systematic epistasis detection. ConclusionsWe provide in silico evidence of RBMS3 as a novel CAD risk gene, acting in epistasis with the established CDKN2B-AS1 9p21.3 risk loci.
- organism: human
- assay: GWAS summary statistics
- research focus: gene regulatory network inference
- research focus: differential expression
- research focus: variant effect prediction
- approach: machine learning (classical)
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cis-epistasis at the LPA locus and risk of coronary artery disease
Lingyao Zeng, Nazanin Mirza‐Schreiber, … Heribert Schunkert·bioRxiv·Jan 23, 2019
- Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.
Krishna G. Aragam, Tao Jiang, … Adam S. Butterworth·medRxiv·May 24, 2021
- Enhancer-targeting CRISPR screens at coronary artery disease loci suggest shared mechanisms of disease risk
Markus O Ramste, Chad S. Weldy, … Thomas Quertermous·medRxiv·Aug 28, 2025
- Transcriptome-wide association study of coronary artery disease identifies novel susceptibility genes
Ling Li, Zhifen Chen, … Heribert Schunkert·Basic Research in CardiologyPeer-reviewed·Feb 17, 2022
- Interpreting coronary artery disease GWAS results: A functional genomics approach assessing biological significance
Katherine Hartmann, Michał T. Seweryn, Wolfgang Sadée·PLoS ONEPeer-reviewed·Feb 22, 2022
- Bivariate GWAS scan identifies six novel loci associated with lipid levels and coronary artery disease
Katherine M. Siewert, Benjamin F. Voight·Circulation Genomic and Precision MedicinePeer-reviewed·Dec 1, 2018